Please try another search
Investing.com - Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) received a Notice of Non-Compliance from Health Canada for its Semaglutide ANDS injection, the company announced Tuesday. The stock,...
Investing.com - Dr. Reddy’s Labs ADR (NYSE: RDY) reported third quarter EPS of $0.20, better than the analyst estimate of $0.20. Revenue for the quarter came in at $1B versus the consensus...
Updates with India open, earnings context Investing.com-- Most Asian stocks advanced on Monday, with Japanese shares hitting record highs amid renewed bets that fiscal dove Sanae Takaichi will secure...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review